CYT-101
/ Cyteph
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 07, 2025
Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer
(PRNewswire)
- "The Phase I study is being conducted in collaboration with Briz Brain & Spine and Newro Foundation....The Phase I trial follows participants through dose-escalation cohorts, with key readouts expected at the end of Q4 2025."
Enrollment closed • P1 data • Glioblastoma
1 to 1
Of
1
Go to page
1